
Source: YouTube
Among women with early breast cancer and a sentinel lymph node that appears to be cancer free on routine evaluation, more extensive lymph node evaluation identifies small areas of cancer in approximately 16% of women. These small, hidden areas of …
It appears that women with early breast cancer who are prescribed treatment with aromatase inhibitors (AIs) are more likely to discontinue or not follow through with this therapy if insurance copayments are high. These results were presented at the 2010 …
Among women at low risk of breast cancer, postmenopausal hormone therapy with estrogen alone may reduce the risk of breast cancer. These results—which warrant additional research and should not be considered conclusive—came from further review of the Women’s Health Initiative …
In a study of women with bone metastases from breast cancer, Xgeva™ (denosumab) delayed bone complications for five months longer than Zometa® (zoledronic acid). These updated results from a Phase III clinical trial were presented at the 2010 San Antonio …
Women with a history of breast cancer appear to prefer the antidepressant Effexor® (venlafaxine) over the antiseizure drug Neurontin® (gabapentin) for treatment of hot flashes. These findings were recently released in the Journal of Clinical Oncology. Hot flashes can be …
We should all work together to find a cure for breast cancer, not even just breast cancer but all cancer’s. No one deserves to go go through the pain and misery of having cancer. This video is in honor of my mom who is currently battling breast cancer for a second time now. This video is also in memorial to Paula Bondy who passed away from cancer in 2002
Source: YouTube
The addition of the targeted drug Avastin® (bevacizumab) to chemotherapy did not improve outcomes among women receiving preoperative chemotherapy for early stage breast cancer. The results of this Phase III clinical trial were presented at the 2010 San Antonio Breast …
In women diagnosed with estrogen receptor (ER) positive HER2 negative breast cancer, obesity may contribute to poorer survival rates. These results were presented at the 2010 San Antonio Breast Cancer Symposium. Obesity is a significant public health concern that can …